Ambulatory continuous femoral nerve blocks decrease time to discharge readiness after tricompartment total knee arthroplasty: a randomized, triple-masked, placebo-controlled study
Brian M Ilfeld, Linda T Le, R Scott Meyer, Edward R Mariano, Krista Vandenborne, Pamela W Duncan, Daniel I Sessler, F Kayser Enneking, Jonathan J Shuster, Douglas W Theriaque, Linda F Berry, Eugene H Spadoni, Peter F Gearen, Brian M Ilfeld, Linda T Le, R Scott Meyer, Edward R Mariano, Krista Vandenborne, Pamela W Duncan, Daniel I Sessler, F Kayser Enneking, Jonathan J Shuster, Douglas W Theriaque, Linda F Berry, Eugene H Spadoni, Peter F Gearen
Abstract
Background: The authors tested the hypotheses that, compared with an overnight continuous femoral nerve block (cFNB), a 4-day ambulatory cFNB increases ambulation distance and decreases the time until three specific readiness-for-discharge criteria are met after tricompartment total knee arthroplasty.
Methods: Preoperatively, all patients received a cFNB (n = 50) and perineural ropivacaine 0.2% from surgery until the following morning, at which time they were randomly assigned to either continue perineural ropivacaine or switch to perineural normal saline. Primary endpoints included (1) time to attain three discharge criteria (adequate analgesia, independence from intravenous analgesics, and ambulation of at least 30 m) and (2) ambulatory distance in 6 min the afternoon after surgery. Patients were discharged with their cFNB and a portable infusion pump, and catheters were removed on postoperative day 4.
Results: Patients given 4 days of perineural ropivacaine attained all three discharge criteria in a median (25th-75th percentiles) of 25 (21-47) h, compared with 71 (46-89) h for those of the control group (estimated ratio, 0.47; 95% confidence interval, 0.32-0.67; P <0.001). Patients assigned to receive ropivacaine ambulated a median of 32 (17-47) m the afternoon after surgery, compared with 26 (13-35) m for those receiving normal saline (estimated ratio, 1.21; 95% confidence interval, 0.71-1.85; P = 0.42).
Conclusions: Compared with an overnight cFNB, a 4-day ambulatory cFNB decreases the time to reach three important discharge criteria by an estimated 53% after tricompartment total knee arthroplasty. However, the extended infusion did not increase ambulation distance the afternoon after surgery. (ClinicalTrials.gov No. NCT00135889.).
Figures





Source: PubMed
Upcoming Clinical Trials
-
October University for Modern Sciences and ArtsRecruiting
-
Uskudar UniversityNot yet recruitingMusculoskeletal Pain | Occupational DiseasesTurkey (Türkiye)
-
Milton S. Hershey Medical CenterAxogen CorporationNot yet recruitingParotid Cancer | Parotidectomy | Frey's Syndrome | Parotidectomy, Patient-reported Outcomes | Parotid Gland Tumor
-
University of the Italian SwitzerlandUniversita di VeronaNot yet recruitingCaregiver Burden | Psychological DistressSwitzerland
-
Ain Shams UniversityNot yet recruitingHip Abductor Insufficiency Following Total Hip Arthroplasty
-
University of CalgaryNot yet recruitingHypospadias | Ureteropelvic Junction ObstructionCanada
-
Reinovax Biologics Co., LTDNot yet recruitingA Phase Ⅲ Clinical Trial of an Investigative 24-valent Pneumococcal Polysaccharide Conjugate VaccinePneumococcal Infectious DiseaseChina
-
Research IncRecruitingPostoperative Nasal Fibrosis After RhinoplastyColombia
-
Abramson Cancer Center at Penn MedicineNot yet recruiting
-
Aligos TherapeuticsNot yet recruitingHealthy ParticipantsUnited States
-
PT Equilab InternationalNestle IndonesiaRecruiting
-
Stanford UniversityNot yet recruiting